Fig. 2
From: Antiproliferative and apoptotic effects of telmisartan in human glioma cells
Effects of ARBs on glioma cell viability. Glioma cells (LN229, U87MG, and LNZ308) were treated with telmisartan (A), valsartan (B), or fimasartan (C) at the indicated concentrations or with vehicle control (DMSO), and cell viability was analyzed using the MTS assay at the indicated time points. Values are expressed relative to those of the control group (n = 3, error bars indicate ± SD). Statistical significance was determined using one-way ANOVA followed by Dunnett's multiple comparison test (*p < 0.05; **p < 0.001; ***p < 0.001). These results showed that only telmisartan decreased the viability of all three glioma cell lines in a dose- and time-dependent manner